These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 4382304)

  • 1. Dual actions of some N-(1-phenylethyl)guanidines on the nictitating membrane of conscious cats.
    Fielden R
    J Pharm Pharmacol; 1967 Apr; 19(4):217-20. PubMed ID: 4382304
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on the antagonism between the optical isomers of N-(1-phenylethyl)guanidine.
    Fielden R; Green AL
    Br J Pharmacol Chemother; 1966 Jan; 26(1):264-70. PubMed ID: 5919510
    [No Abstract]   [Full Text] [Related]  

  • 3. A comparison of aralkylamines and aralkylguanidines as antagonists of adrenergic neurone blockade.
    Fielden R; Green AL
    J Pharm Pharmacol; 1966 Nov; 18(11):721-8. PubMed ID: 4382048
    [No Abstract]   [Full Text] [Related]  

  • 4. Sympathetic nervous system blocking agents. V. Derivatives of isobutyl-, t-butyl-, and neopentylguanidine.
    Short JH; Ours CW; Ranus WJ
    J Med Chem; 1968 Nov; 11(6):1129-35. PubMed ID: 5680024
    [No Abstract]   [Full Text] [Related]  

  • 5. Analysis of the central vasomotor effects of (-)-N-(1-phenylethyl)guanidine, a new adrenergic neuron blocking agent.
    Bapat SK; Dhawan BN; Srimal RC
    Can J Physiol Pharmacol; 1969 Aug; 47(8):725-9. PubMed ID: 5820115
    [No Abstract]   [Full Text] [Related]  

  • 6. Facilitation of ganglionic transmission by some adrenergic neurone blocking drugs.
    Farmer JB; Rand MJ; Wilson J
    Int J Neuropharmacol; 1966 May; 5(3):241-6. PubMed ID: 4380550
    [No Abstract]   [Full Text] [Related]  

  • 7. Sympathetic nervous system blocking agents. 3. Derivatives of benzylguanidine.
    Short JH; Darby TD
    J Med Chem; 1967 Sep; 10(5):833-40. PubMed ID: 6057834
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacology of N-[2-(2,6-xylyloxy)ethyl]-guanidine sulphate; an adrenergic neurone blocking agent.
    Barron DI; Natoff IL; Vallance DK
    Br J Pharmacol Chemother; 1965 Oct; 25(2):534-44. PubMed ID: 5866731
    [No Abstract]   [Full Text] [Related]  

  • 9. [On the pharmacology of N-(2-guanidinoethyl)-4-methyl-1,2,3,6-tetrahydropyridine, a new antihypertensive-acting compound].
    Kroneberg G; Schlossmann K; Stoepel K
    Arzneimittelforschung; 1967 Feb; 17(2):199-207. PubMed ID: 5631784
    [No Abstract]   [Full Text] [Related]  

  • 10. A comparative study of the noradrenaline-depleting and sympathetic-blocking actions of guanethidine and (-)-beta-hydroxyphenethylguanidine.
    Fielden R; Green AL
    Br J Pharmacol Chemother; 1967 May; 30(1):155-65. PubMed ID: 6039969
    [No Abstract]   [Full Text] [Related]  

  • 11. Optical isomers of beta-hydroxyphenethylguanidine: effects on heart noradrenaline and on sympathetic blockade.
    Fielden R; Green AL
    Br J Pharmacol Chemother; 1968 Feb; 32(2):350-9. PubMed ID: 5646312
    [No Abstract]   [Full Text] [Related]  

  • 12. Influence of new guanidine derivatives on ganglionic and neuromuscular transmission.
    Kadzielawa K; Gumulka W
    Arch Int Pharmacodyn Ther; 1967 Dec; 170(2):297-309. PubMed ID: 4294771
    [No Abstract]   [Full Text] [Related]  

  • 13. The adrenergic neurone blocking action of [2-(methylphenylamino)ethyl]guanidine sulfate. I.
    Ozawa H; Sato S
    Chem Pharm Bull (Tokyo); 1966 Nov; 14(11):1291-7. PubMed ID: 5979175
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of phentolamine on responses of the normal and of the denervated nictitating membrane of the pithed cat to tyramine.
    Hoszowska-Owczarek A
    Arch Int Pharmacodyn Ther; 1969 Mar; 178(1):9-25. PubMed ID: 4390922
    [No Abstract]   [Full Text] [Related]  

  • 15. The adrenergic blocking activity of two phenoxathiinium compounds.
    Shriver SL; Rudzik AD
    Arch Int Pharmacodyn Ther; 1967 Sep; 169(1):211-20. PubMed ID: 6055130
    [No Abstract]   [Full Text] [Related]  

  • 16. The preparation and properties of (+)- and (--)-guanoxan.
    Stenlake JB; Breimer DD; Smail GA; Stafford A; Bowman WC
    J Pharm Pharmacol; 1968 Dec; 20():Suppl:82S+. PubMed ID: 4388179
    [No Abstract]   [Full Text] [Related]  

  • 17. POTENTIAL ANTIHYPERTENSIVE AGENTS. SOME GUANIDINE DERIVATIVES.
    BARRON DI; BAVIN PM; DURANT GJ; NATOFF IL; SPICKETT RG; VALLANCE DK
    J Med Chem; 1963 Nov; 6():705-11. PubMed ID: 14184930
    [No Abstract]   [Full Text] [Related]  

  • 18. [On the pharmacology of cyclohexylamine, a substance found in human urine after intake of cyclamates].
    Classen HG; Marquardt P
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1969; 263(1):263-4. PubMed ID: 5804285
    [No Abstract]   [Full Text] [Related]  

  • 19. THE SYNTHESIS AND PHARMACOLOGY OF SOME SUBSTITUTED 1,3-BENZODIOXOLES AND 1,4-BENZODIOXANS.
    BAINES MW; COBB DB; EDEN RJ; FIELDEN R; GARDNER JN; ROE AM; TERTIUK W; WILLEY GL
    J Med Chem; 1965 Jan; 8():81-90. PubMed ID: 14287271
    [No Abstract]   [Full Text] [Related]  

  • 20. Antagonistic phenomena between crystalline tetrodotoxin and guanidines on sympathetic nervous systems.
    Ozawa H; Sugawara K
    Chem Pharm Bull (Tokyo); 1969 Aug; 17(8):1605-10. PubMed ID: 5348889
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.